Cipla USA is recalling the affected lot due to “short fill” whereas Glenmark Pharma is recalling 3,264 bottles of Diltiazem Hydrochloride extended-release capsules indicated for high blood pressure, USFDA said.
News
Cipla, Glenmark recall drugs from US market: USFDA
May 14, 2024Cipla USA is recalling the affected lot due to “short fill” whereas Glenmark Pharma is recalling 3,264 bottles of Diltiazem Hydrochloride extended-release capsules indicated for high blood pressure, USFDA said.